303 related articles for article (PubMed ID: 31833468)
1. Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Retain High Efficacy for Treatment of Uncomplicated
Han KT; Lin K; Myint MK; Thi A; Aye KH; Han ZY; Moe M; Bustos MD; Rahman MM; Ringwald P; Simmons R; Markwalter CF; Plowe CV; Nyunt MM
Am J Trop Med Hyg; 2020 Mar; 102(3):598-604. PubMed ID: 31833468
[TBL] [Abstract][Full Text] [Related]
2. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
Ebong C; Sserwanga A; Namuganga JF; Kapisi J; Mpimbaza A; Gonahasa S; Asua V; Gudoi S; Kigozi R; Tibenderana J; Bwanika JB; Bosco A; Rubahika D; Kyabayinze D; Opigo J; Rutazana D; Sebikaari G; Belay K; Niang M; Halsey ES; Moriarty LF; Lucchi NW; Souza SSS; Nsobya SL; Kamya MR; Yeka A
Malar J; 2021 Dec; 20(1):484. PubMed ID: 34952573
[TBL] [Abstract][Full Text] [Related]
5. High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
Warsame M; Hassan AM; Hassan AH; Jibril AM; Khim N; Arale AM; Gomey AH; Nur ZS; Osman SM; Mohamed MS; Abdulrahman A; Yusuf FE; Amran JGH; Witkowski B; Ringwald P
Malar J; 2019 Jul; 18(1):231. PubMed ID: 31296223
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
[TBL] [Abstract][Full Text] [Related]
7. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
Omondi P; Burugu M; Matoke-Muhia D; Too E; Nambati EA; Chege W; Musyoka KB; Thiongo K; Otinga M; Muregi F; Kimani F
Malar J; 2019 Dec; 18(1):398. PubMed ID: 31801562
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Dorkenoo AM; Warsame M; Ataba E; Hemou M; Yakpa K; Sossou E; Mitigmsagou M; Teou CD; Caspar E; Ma L; Djadou KE; Atcha-Oubou T; Rasmussen C; Menard D
Malar J; 2024 Apr; 23(1):92. PubMed ID: 38570791
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
[TBL] [Abstract][Full Text] [Related]
10. High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania.
Mandara CI; Kavishe RA; Gesase S; Mghamba J; Ngadaya E; Mmbuji P; Mkude S; Mandike R; Njau R; Mohamed A; Lemnge MM; Warsame M; Ishengoma DS
Malar J; 2018 Jul; 17(1):261. PubMed ID: 29996849
[TBL] [Abstract][Full Text] [Related]
11. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
Assefa DG; Yismaw G; Makonnen E
Malar J; 2021 Aug; 20(1):340. PubMed ID: 34384431
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
[TBL] [Abstract][Full Text] [Related]
14. Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
Yeka A; Wallender E; Mulebeke R; Kibuuka A; Kigozi R; Bosco A; Kyambadde P; Opigo J; Kalyesubula S; Senzoga J; Vinden J; Conrad M; Rosenthal PJ
J Infect Dis; 2019 Mar; 219(7):1112-1120. PubMed ID: 30418593
[TBL] [Abstract][Full Text] [Related]
15. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V
Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
[TBL] [Abstract][Full Text] [Related]
18. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
19. Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda.
Angwe MK; Mwebaza N; Nsobya SL; Vudriko P; Dralabu S; Omali D; Tumwebaze MA; Ocan M
PLoS One; 2024; 19(6):e0305064. PubMed ID: 38837973
[TBL] [Abstract][Full Text] [Related]
20. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]